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The safety and short-term therapeutic benefit of mul•
tilesion percutaneous transluminal coronary angioplasty 
was assessed in 135 patients, 66 of whom had a minimum 
of 6 months of follow-up study. Primary success, defined 
as successful dilation of the most critical lesion or all 
lesions attempted without major in-hospital complica•
tions was obtained in 117 (87 %) of the 135 patients. 
Cardiac complications associated with the procedure were 
uncommon; prolonged angina occurred in 5% and myo•
cardial infarction in 3 %; emergency coronary bypass 
surgery was performed in 4% of the patients. There were 
no deaths. 
Complete revascularization was achieved in 46 % of 
the 117 patients with a primary success. Of the 66 pa•
tients eligible for 6 month follow-up, 80% had an un•
complicated course and required no Jurther procedures. 
Clinical improvement by at least one angina functional 
class was observed in 90% ofthe patients. Cardiac events 
Percutaneous transluminal coronary angioplasty is a safe 
and clinically effective therapeutic modality for patients with 
single vessel coronary disease (1-4). The growing popu•
larity of the technique has resulted in an increasing number 
of patients undergoing coronary angioplasty and a concom•
itant increase in the proportion of patients referred for mul•
tivessel disease. 
Several centers (5-10) have reported a low incidence of 
angioplasty-related complications in patients who undergo 
multiple dilations during the same procedure. However, 
clinical and angiographic follow-up are relatively limited, 
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such as the need for a second revascularization proce•
dure were significantly more common in patients who 
had incomplete versus complete revascularization (35 
versus 9%; p = 0.018). Repeat coronary angiography 
performed an average of 5 months after angioplasty re•
vealed restenosis in 18 of 22 symptomatic patients and 
3 of 9 asymptomatic patients. Restenosis occurred at the 
site of a single dilation in 12 patients, at two sites in 8 
patients and at three sites in 1 patient. 
Thus, multilesion coronary angioplasty is an impor•
tant therapeutic option for selected patients with mul•
tivessel disease and can be performed with relatively low 
risk. Improvement in angina status can be expected even 
in patients who have incomplete revascularization. The 
need for a second revascularization procedure is signif•
icantly greater when incomplete revascularization is 
obtained. 
(J Am Coll CardioI1985;6:983-91) 
and few studies address the importance of the degree of 
revascularization obtained and its effect on functional re•
suits. The clinical significance of number of diseased vessels 
and left ventricular performance as determinants of long•
term prognosis is well documented (l1-14). In this study, 
we describe our experience with multilesion coronary an•
gioplasty in 135 patients, and report on 66 patients eligible 
for 6 month follow-up in whom a primary success was 
achieved. The extent of revascularization obtained at the 
time of initial angioplasty and its relation to subsequent 
cardiac events is discussed. 
Methods 
Study patients. Four hundred fifty consecutive patients 
underwent percutaneous transluminal coronary angioplasty 
at our hospital between May 1983 and September 1984; 221 
patients had multivessel disease. The study group consists 
of 135 consecutive patients who had two or more dilations 
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performed during the same procedure. Six patients under•
went a multiple dilation within 2 weeks of acute myocardial 
infarction. Of the 92 patients who had unstable angina, 37 
had new onset angina and 4 patients had acute coronary 
insufficiency. The average age of the 102 men and 33 women 
was 56 years (range 29 to 75). Clinical and angiographic 
patient characteristics are described in Table 1. 
Each patient had 1) angina refractory to medical therapy 
or evidence of myocardial ischemia (abnormal exercise elec•
trocardiogram, reversible thallium-20l perfusion defect or 
abnormal pacing lactate study); 2) stenoses considered "ap•
proachable" based on location, severity, length, eccentric•
ity; and 3) accessibility of the dilating catheter to two or 
more lesions. Transtenotic pressure gradient measurements 
were obtained for coronary luminal narrowings of 50 to 
69% when the stenosis was in the proximal or mid segment 
of a large vessel. The lesion was dilated if the gradient was 
greater than 20 mm Hg. Angioplasty of occluded vessels 
that supplied an akinetic left ventricular segment was not 
attempted. 
Multilesion angioplasty was not attempted in 108 patients 
with multi vessel disease because of an occluded vessel in 
17 patients, a coronary narrowing of 50 to 69% in a small 
vessel or an associated pressure gradient of less than 20 mm 
Hg in 46 patients and residual disease proximal to a dilated 
graft in 10 patients. The critical lesion was the only lesion 
dilated in 35 patients. 
Table 1. Clinical and Angiographic Description of 135 Patients 
With Multiple Coronary Angioplasty 
No. %* 
Clinical variables 
Age 2 70 years 9 8 
CCS angina class 2 III 79 59 
Unstable angina 92 63 
Prior MI 60 44 
History of CHF 4 3 
Prior CABO 14 \0 
Angiographic variables 
One vesselt 22 16 
Two vessel 65 48 
Three vessel 48 36 
Proximal LAD 39 29 
Proximal LAD and proximal LCx 12 9 
Left main coronary disease:j: 2 2 
LV score 2 \0 21 16 
Occluded vessel not attempted 31 23 
*Percent of 135 patients. not mutually exclusive; tclassification of 
number of diseased vessels (2 50% narrowing); :j:both patients had previous 
coronary artery bypass grafting. CABO = coronary artery bypass grafting; 
CCS = Canadian Cardiovascular Society; CHF = congestive heart failure; 
LAD = left anterior descending coronary artery; LCx = lefi circumflex 
coronary artery; LV score = left ventricular contraction score (CASS 
definition); MI = myocardial infarction; PTCA = percutaneous translu•
minal coronary angioplasty. 
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Each patient's film was evaluated before the procedure 
by a cardiovascular surgeon and considered to be acceptable 
candidates for coronary bypass surgery. The angioplasty 
procedure was carried out with an operating room and car•
diac surgical team on standby. 
Cardiac catheterization and angioplasty procedure. 
Selective right and left coronary angiography was performed 
in multiple views including craniocaudal and caudocranial 
angular sagittal views. Coronary stenosis was expressed as 
percent luminal narrowing compared with the nearest nor•
mal arterial segment. The extent of coronary disease and 
left ventricular contraction score were classified according 
to the coding system described in the Coronary Artery Sur•
gery Study (CASS) study (15). In the present study, a nar•
rowing of 50% or more of luminal diameter was considered 
significant. 
Routine 24 hour premedication included acetylsalicylic 
acid (650 mg), dipyridamole (200 mg) and nifedipine (40 
mg). During angioplasty, a bolus of 10,000 units of heparin 
was given intravenously and a low molecular weight dextran 
infusion was started. Sublingual nifedipine (10 to 20 mg) 
and intracoronary nitroglycerin (200 JLg) were administered 
as necessary. Routine postangioplasty medication included 
acetylsalicylic acid (325 mg daily), dipyrimadole (75 mg 
three times daily) and nifedipine (10 mg four times daily) 
for 6 months in patients who did not have contraindications 
or major side effects. 
The percutaneous trans luminal coronary angioplasty pro•
cedure was performed by the transfemoral approach in 130 
patients and the brachial approach in 5 patients using stan•
dard techniques and a steerable catheter system (16,17). 
Each balloon inflation was maintained for 30 to 90 seconds 
at a pressure of 6 to 10 torr. The most severe narrowing 
supplying the largest amount of jeopardized myocardium 
(critical stenosis) was always attempted first. If the critical 
stenosis could not be successfully dilated, the procedure 
was terminated and coronary bypass surgery was recom•
mended. The stenosis was considered successfully dilated 
when a 30% reduction in luminal diameter stenosis was 
obtained and the residual narrowing was less than 50%. All 
attempted lesions were measured in two perpendicular views 
using calipers, and the lesions were compared with the near•
est normal proximal segment. The average of both views 
determined the percent reduction in luminal diameter. A 
patient was considered to have a primary success when the 
critical stenosis or dilation of all lesions attempted was 
achieved with immediate clinical improvement in angina 
status and without major in-hospital complications. Com•
plete revascularization was defined as successful dilation of 
all major coronary or branch vessels and absence of residual 
stenosis of 50% or greater in any vessel. 
Functional evaluation and follow-up. A standard 
symptom-limited exercise test was performed according to 
the Bruce protocol with 12 electrocardiographic leads before 
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and within 10 days after the procedure (3), Heart rate and 
cuff blood pressure were recorded at each work load and 
presence or absence of symptoms was noted, Administration 
of cardiac medications was stopped 24 hours before testing 
when possible, The electrocardiogram was monitored con•
tinuously and recorded each minute during and for 5 minutes 
after exercise using a Marquette Case II computerized sys•
tem, All patients were in a fasting state and had not smoked 
for at least 2 hours before the test The exercise electro•
cardiogram was considered abnormal if horizontal or down•
sloping ST segment depression of 1 mm or greater or up•
sloping ST segment depression of 2 mm or greater at 0,08 
second after the J point occurred either during or after the 
test (18), In patients who had ST segment depression at 
rest, an additional ST segment depression of 1 mm was 
required to classify the test as abnormal, Exercise test results 
were available before angioplasty in 67 of 117 patients with 
a primary success and after angioplasty in 95 patients; 57 
patients had paired exercise test data, Exercise testing was 
not performed in 50 patients before angioplasty because of 
crescendo angina, acute coronary insufficiency, continuing 
angina after infarction, scheduling difficulties or patient or 
physician refusal, 
Follow-up. All patients with a primary success who were 
eligible for 6 month follow-up were contacted, The closure 
date for analysis was September 30, 1984, Functional status 
and presence or absence of cardiac complications were de•
termined by telephone interview or clinical visit An elective 
repeat coronary angiogram was recommended to all patients 
at 6 months after the coronary angioplasty or earlier if clin•
ically indicated, Of 66 patients who had a primary success 
and were eligible for 6 month follow-up, 31 (47%) under•
went repeat coronary angiography, Restenosis was defined 
as an increase in the luminal diameter of 30% or greater 
filmed in the same view used in the immediate postangio•
plasty angiogram, or a luminal narrowing at the site of 
dilation of 50% or greater or both, 
Statistical analysis. Nonparametric differences were 
examined using a chi-square or Fisher's exact test for small 
sample size, Parametric differences were examined using a 
t test A p value of less than 0,05 was considered statistically 
significant 
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Results 
Angiographic success. Primary success was obtained in 
117 (87%) of 135 patients, Angiographic success was ob•
tained in 80% (264 of 329) of the lesions attempted, The 
average number of lesions dilated was 2,4 per patient and 
was 2, I, 2,3 and 2,7 for patients with one, two and three 
vessel disease, respectively (Table 2), Of the 22 patients 
with single vessel disease 17 and 3 patients, respectively, 
had two and three or more lesions dilated (Fig, I); in 2 
patients angioplasty was attempted on only one lesion be•
cause of failure to dilate the critical stenosis, Among the 
65 patients with two vessel disease, 47 and 17, respectively, 
had two and three or more lesions dilated, Two ot more 
dilations were performed in the same vessel in 34 patients 
and in two different vessels in 30 patients, The critical lesion 
could not be dilated in one patient Of the 48 patients with 
three vessel disease, 19, 15 and 10 patients, respectively, 
had two, three and four or more lesions dilated (Fig, 2), 
Two or more dilations were done in the same vessel in 1 
patient, in two vessels in 20 patients and in three vessels 
in 23 patients, The critical lesion could not be dilated in 
four patients, 
Complications in hospital. Of the 135 patients, 5% had 
a major arrhythmia requiring direct current cardioversion, 
Prolonged angina without evidence of myocardial infarction 
occurred in seven patients (5%), Myocardial infarction con•
firmed by serial electrocardiogram and cardiac enzymes oc•
curred in four patients (3%), Emergency coronary bypass 
surgery was performed in six patients (4%), There were no 
deaths, The incidence of major complications were not sig•
nificantly greater in patients with more severe angina, those 
with previous myocardial infarction or patients with mul•
tivessel disease, 
An occlusive dissection occurred in four patients and total 
occlusion of the vessel with attempted dilation in four pa•
tients, Side branch occlusion occurred after balloon inflation 
in two patients without clinical evidence of myocardial isch•
emia, One patient developed coronary vasospasm which 
resolved after intracoronary nitroglycerin, Of the eight pa•
tients who developed a complete occlusion, one of three, 
one of one and two of four patients, respectively, who had 
Table 2. Completeness of Revascularization After Multiple Coronary Angioplasty 
No, of No, of Lesion Dilation Patient 
Revascularization 
Vessels Patients* Success Rate/Pt Success Complete Incomplete 
22 44/46 (96%) 2,1 20122 (91%) 18 (90%) 2 (10%) 
2 65 122/152 (80%) n 59/65 (91%) 28 (47%) 31 (53%) 
3 48 98/131 (75%) 2,7 38/48 (79%) 8 (21%) 30 (79%) 
*18 patients were excluded because of unsuccessful percutaneous transluminal coronary angioplasty (see 
text), Pt = patient 
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Figure 1. Multilesion tandem dilation (lower panels) of the dif•
fusely diseased right coronary artery (top panels) of a 53 year old 
man with class III angina. Five lesions in this vessel were suc•
cessfully dilated. The left coronary artery was not significantly 
diseased. Left panels, Left oblique view; right panels, right oblique 
view. 
left circumflex, right or left anterior descending coronary 
artery occlusion developed a myocardial infarction. 
Completeness of revascularization. Complete revas•
cularization was achieved in 54 (46%) of 117 patients with 
a primary success. As expected, the angiographic and clin•
ical success rate and percent of patients achieving complete 
revascularization were significantly lower in patients with 
more diffuse disease (p < 0.01) (Table 2). The cause of 
incomplete revascularization was unsuccessful dilation of a 
noncritical lesion in 15 patients, an occluded vessel on which 
dilation was not attempted in 20 patients and a stenosis of 
50 to 69% in 28 patients on which angioplasty was not 
attempted because of either location (nondominant vessel, 
small secondary branch vessel) or an insignificant transten•
otic gradient « 20 mm Hg). Ten of the latter patients had 
a coexistent occluded vessel. 
Early functional results. All patients who had a pri•
mary success demonstrated clinical improvement with a re•
duction in symptoms or improved exercise tolerance. Ex•
ercise-induced angina occurred in 11 (12%) and an abnormal 
exercise electrocardiogram in 30 (32%) of the 95 patients 
with postangioplasty exercise test data. Exercise-induced 
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angina occurred in 1 (2%) of 46 patients with complete 
revascularization versus 10 (20%) of 49 patients with in•
complete revascularization (p = 0.014); an abnormal ex•
ercise electrocardiogram occurred in 9 versus 21 patients, 
respectively (p = 0.015). 
Of 57 patients who had paired exercise test data before 
and after angiopiasty, exercise-induced angina occurred in 
56% of patients before the procedure compared with only 
11 % of patients after angioplasty (p < 0.01) (Table 3). 
Exercise-induced ST segment depression of more than 1 
mm occurred in 75% of patients before angioplasty versus 
32% of patients after the procedure (p < 0.01). 
After 'patients were stratified according to completeness 
of revascularization, the number of patients with exercise•
induced angina was reduced to zero when complete rev as•
cularization was obtained (p < 0.01); the difference was 
less marked in the patients who had incomplete revascu•
larization (p < 0.05) (Table 3). The incidence of exercise•
induced ST segment depression of more than 1 mm was 
significantly reduced in patients who had complete and in•
complete revascularization compared with before angio•
plasty. The increase in peak treadmill time was significantly 
greater after coronary angioplasty and was similar in patients 
with incomplete and in those with complete revascularization. 
Six month evaluation. After hospital discharge, 66 pa•
tients with primary success were eligible for 6 month follow•
up (Fig. 3); 53 (80%) had an uncomplicated course and 
required no further procedures (Table 4). One patient (2%) 
sustained a myocardial infarction. Elective coronary bypass 
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surgery was performed in 6 patients (9%) and repeat per•
cutaneous transluminal coronary angioplasty in 6 patients 
(9%) and repeat percutaneous transluminal coronary angio•
plasty in 6 patients (9%) either because of restenosis in II 
patients or disease progression in 1 patient. One patient died 
after coronary bypass surgery during an admission for un•
stable angina 4 months after angioplasty. 
The incidence of cardiac events was significantly higher 
in patients who had incomplete revascularization than in 
those with complete revascularization (p = 0.018) (Table 
4). The difference was related to the significantly greater 
requirement for a second revascularization procedure (either 
coronary angioplasty or bypass surgery) in the incompletely 
revascularized group (32 versus 6%; versus p = 0.014). 
Myocardial infarction occurred in one patient who had com-
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Figure 2. Quadruple vessel coronary angioplasty in a 57 year old 
man. The 90. 80 and 95% stenoses in the left anterior descending, 
intermediate and left circumflex coronary artery, respectively (top 
left), were successfully dilated (bottom left). A 90% distal right 
coronary stenosis (top right) was also successfully dilated (bottom 
right). The patient experienced no complications and at 6 month 
follow-up maintains an excellent clinical and angiographic result. 
plete revascularization. When the patients with incomplete 
revascularization were analyzed according to presence or 
absence of an occluded coronary vessel at the time of the 
initial procedure, the incidence of late complications was 
not significantly different in the two groups. 
Clinical improvement by at least one angina class was 
observed in 90% of the 59 patients without cardiac com-
Table 3. Exercise Results Before (Pre) and Within 10 Days (Post) of Multiple 
Coronary Angioplasty 
Exercise ST Depression 
Exercise Duration 
Angina 2' I mm 
(seconds ± SD) 
(% patients) (% patients) 
N Pre Post Pre Post Pre Post 
Total 57 56 II * 75 32* 376 ± 13g 502 ::r 135* 
Degree of 
revascularization 
Complete 27 59 0* 7g 26* 376 ± 147 514 ± 155* 
Incomplete 30 53 20t 73 37t 376 ± 133 492 ± 117* 
*p < 0.01; tp < 0.05. 
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INELIGIBLE FOR ELIGIBLE FOR 
6 MO FOLLOW-UP-51 6 MO FOLLOW-UP-66 
ASYMPTOMATlC-37 
Figure 3. Flow diagram of the follow-up results of the 135 patients 
who underwent multilesion coronary angioplasty. Of 66 patients 
eligible for 6 month follow-up, 53 had no cardiac events, and 37 
were asymptomatic (see text). 
plications who were eligible for 6 month follow-up (p < 
0.001) (Fig. 4). The six patients who underwent coronary 
bypass surgery and a single patient who had a myocardial 
infarction in the interim were excluded from this analysis. 
Whereas 97% of the 59 patients were in Canadian Cardio•
vascular Society angina functional class II or higher before 
coronary angioplasty, 63% were asymptomatic 6 months 
later. A second coronary angioplasty was performed in six 
patients because of recurrent symptoms. The improvement 
in angina functional class was significant, even in patients 
with incomplete revascularization, although the improve•
ment was less marked than for those with complete 
revascularization. 
The total number of patients requiring a second revas•
cularization procedure (including those with in-hospital 
complications) was 27; 6 had a repeat coronary angioplasty 
and 21 underwent coronary bypass surgery. 
Follow-up coronary angiography. Among the 117 pa•
tients with an initial primary success, 31 underwent coronary 
angiography an average of 5 (range I to 12) months after 
the angioplasty. Among the 22 patients studied because of 





Complete Incomplete (%) 
Patients 
Total number 35 31 66 
Without cardiac events 91 65t 80 
Cardiac events 
Repeat PTCA 3 16* 9 
CABG 3 16* 9 
MI 3 0 2 
Death 0 3 2 
CABG, MI or death 6 16 11 
*p = 0.06; tp = 0.018. Event rate = not mutually exclusive. Ab•
breviations as in Table I. 
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recurrent anginal symptoms, 18 had a restenosis an average 
of 4 (range I to 10) months after the procedure. The reste•
nosis occurred at the site of a single dilation in 10 patients, 
at two sites in 7 patients and at three sites in I patient. 
Seven patients underwent a second percutaneous translu•
minal coronary angioplasty, six had coronary bypass graft•
ing and five received medical therapy. In the four symp•
tomatic patients who had eight lesions dilated and no 
restenosis, none had residual coronary stenosis of greater 
than 50%. Among the nine asymptomatic patients studied 
electively 9 (range 5 to 12) months after angioplasty, three 
had restenosis. The restenosis occurred at the site of a single 
dilation in two patients and at two sites in one patient. Each 
asymptomatic patient received medical therapy. 
Of the 71 coronary stenoses dilated in the 31 patients. 
31 (44%) developed a restenosis. The restenosis rate is 
higher than would normally be expected because of the bias 
toward restudy in symptomatic patients. The degree of re•
stenosis was similar to the original luminal narrowing in 15 
stenoses, less than the original narrowing in 13 cases and 
greater than the original narrowing but less than total oc•
clusion in 3 cases. 
Two patients developed a neW atherosclerotic narrowing 
of 50% or greater in an area contiguous to the area of 
dilation. In one patient with proximal left anterior descend•
ing coronary artery disease in whom balloon inflation in•
volved the distal segment of the left main coronary artery, 
Figure 4. Angina functional class (Canadian Cardiovascular So•
ciety) was significantly improved 6 months after percutaneous 
trans luminal coronary angioplasty (PTCA) compared with the sta•
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an initial 30% left main narrowing progressed to 60% at 
repeat study, In the second patient a new 90% narrowing 
developed in the right coronary artery immediately proximal 
to the dilation site, 
Discussion 
Indications for coronary angioplasty have expanded in 
recent years as a result of increased operator experience, 
improved "steerable" catheter systems and favorable im•
mediate and short-term results (4,19), High success rates 
reported in several clinical patient subsets have stimulated 
physicians to attempt angioplasty procedures in patients with 
more diffuse coronary disease, However, the role of mul•
tilesion coronary angioplasty in patients with multivessel 
disease is still being explored and many issues remain un•
resolved. Does multiple lesion dilation increase the risk of 
angioplasty-related complications? When revascularization 
is incomplete, is important symptomatic relief to be ex•
pected and is the incidence of cardiac events reduced? Is 
the restenosis rate per patient higher for multilesion dilation? 
Does increased catheter manipulation time increase the risk 
of immediate complications or traumatize proximal coronary 
vasculature and accelerate atherosclerosis? Our data attempt 
to address some of these issues. 
Angioplasty-related complications. These were rela•
tively uncommon in this study, and did not appear to be 
more numerous than compiications reported for single lesion 
angioplasty (20). The percent of patients requiring urgent 
coronary bypass surgery or sustaining a myocardial infarc•
tion was similar to the percent reported by others of patients 
requiring multilesion angioplasty (5,8-10,19) (Table 5). In 
the present study, angiographic success meant a 30% re•
duction in luminal diameter stenosis and a less than 50% 
residual narrowing. This definition of success is more strin•
gent than that of some earlier reports (10), which required 
only a 20% reduction in luminal diameter stenosis. There 
were no deaths in the present series, nor was the risk of an 
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early complication significantly greater in patients who had 
unstable angina or previous myocardial infarction. 
Degree of revascularization. Complete revasculariza•
tion was obtained in approximately half of the patients who 
had a primary success. The percent of patients with complete 
revascularization would have been higher if dilation of sten•
oses of 50 to 69% had been attempted. Our angioplasty 
strategy precluded dilation of these moderate atherosclerotic 
narrowings from the outset. This approach was based on 
prognostic data from the Duke registry (14), which indicated 
that lesions greater than 70% were among the more impor•
tant determinants of 5 year cardiac event rates in medically 
treated patients; concomitant stenoses of 50 to 69% were 
associated with significantly less morbidity and mortality. 
A small but significant risk is associated with dilation of 
moderate athersclerotic lesions. Ischinget et al. (21) com•
pared the results of studies of 64 patients with luminal nar•
rowings of less than 60% with the results of 330 studies of 
patients with narrowings greater than 60%. Although the 
primary success rate in the 64 patients was 90%, 4 patients 
developed a myocardial infarction. In the 29% of 58 patients 
with mild stenoses who developed restenoses, the average 
degree of narrowing was greater than that of the original 
lesion on which dilation was attempted (73 ± 15 versus 
52 ± 7%). In many of the patients in this early series dilation 
was attempted before the era of the steerable catheter device. 
Our data, showing an increased incidence of symptoms and 
the need for a second revascularization procedure in patients 
with nondilated residual disease and the relative absence of 
angiographic follow-up data for patients who have under•
gone coronary angioplasty for luminal narrowings of 50 to 
69% using newer steerable catheter systems, indicate a need 
for additional research in this area. 
We did not attempt to routinely dilate totally occluded 
vessels even though this would have increased the proportion 
of patients who achieved complete revascularization. Sev•
eral authors (22-25) reported primary success rates of 56, 
54,75 and 73%, respectively, for totally occluded vessels. 
Table 5. Comparative Reported Results for Multilesion Coronary Angioplasty 
Complications (%) Late Complications 
Repeat 
Reference Angiographic MVD Urgent A vg Follow-up PTCA CABG MI 
(first author) No. Success (%) CABG MI Death No. (mo) (%) (%) (%) 
Hartzler (19) 313 745/814 (92%) NA 2 90 10 8 NA NA 
Vlietstra (9) 100 721100 (72%)* 100 6 2 0 55 >6 NA 16 NA 
Cowley (8) 72 179/195 (92%) 100 3 4 0 27 26 11 19 4 
Dorros (10) 309 599/685 (87%) 64 4 4 239 >7 17 (, <I 
Knudtson (5) 141 125/141 (89%) 100 4 2 2 62 >6 NA NA NA 
Present series 135 264/329 (80%) 84 4 3 0 66 >6 9 9 2 
'Patient success; see text for definition of percent angiographic success. Avg = average; MvD = multi vessel disease; NA = not available; other 
abbreviations as in Table I. 
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However, the early reocclusion rate was high (43%) in two 
of the studies (22,24). Additional data are needed to deter•
mine long-term benefits of recanalizing occluded vessels, 
many of which supply areas of previous infarcted myocardium. 
Complet~ versus incomplete revascularization. The 
percent of patients achieving complete revascularization in 
this study was lower in patients who had three vessel dis•
ease. The initial success rate per lesion with attempted di•
lation was less than that in patients with single vessel disease 
(75 versus 96%; p < 0.01), and 35% of the 48 patients with 
three vessel disease had totally occluded vessels. The clin•
ical significance of failing to achieve complete revascular•
ization cannot be completely assessed from our study be•
cause of the relatively short 6 to 12 month foliow-up period. 
However, residual symptoms requiring a second revascu•
larization procedure were significantly more common in the 
incompletely revascularized group. Residual myocardial 
ischemia, determined by persistence of exercise-induced an•
gina, was also more common in patients who had incomplete 
revascularization even though a significant improvement in 
angina functional class and treadmill work time was achieved. 
Thus, multilesion coronary angioplasty offers consider•
able symptomatic palliation in patients with incomplete re•
vascularization but is not a complete cure. The long-term 
results of failing to achieve complete revascularization with 
multilesion coronary angioplasty may be compared with 
postoperative data of patients who have coronary bypass 
surgery. The incidence of return of angina and cardiac events 
(myocardial infarction, death) is greater in patients with 
multi vessel disease in whom a lesser degree of revascular•
ization is obtained (26-28). Although important sympto•
matic relief may be achieved with mllltilesion angioplasty 
in patients with three vessel coronary disease, the presence 
of major stress-induced ischemia after angioplasty should 
prompt early restudy and aggressive management. The re•
sults of the European Coronary Surgery Study have shown 
improved survival rates in mildly symptomatic patients with 
three vessel disease treated surgically compared with med•
ical therapy (29) and the CASS trial has shown improved 
survival in patients with three vessel disease and impaired 
left ventricular function treated angioplasty (30). 
Restenosis after angioplasty. The early clinical assess•
ment of restenosis in patients after multi lesion angioplasty 
for multi vessel coronary disease is more difficult than for 
patients with single vessel disease. Residual myocardial 
ischemia after angioplasty in patients with multi vessel dis•
ease may indicate restenosis, incomplete revascularization 
or progression of coronary disease. Only 2 of the 31 patients 
we stUdied for an average of 5 months after angioplasty had 
disease progression. However, 18 (82%) of the 22 patients 
studied because of recurrent symptoms had developed a 
restenosis. In 8 (44%) of the patients, the restenosis occurred 
at more than one site, confirming the data of Zaidi et at. 
(7) and Mata et at. (31), who found that when restenosis 
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occurred in patients with multi lesion dilation, it frequently 
occurred at more than one site. The cause of this phenom•
enon is not completely understood and in our series could 
not be completely assessed because of the relatively small 
number of events. Multilesion restenosis did not appear to 
be related to any specific clinical or angioplasty variables 
measured. 
Restenosis was significantly less common in asymptoc 
matic patients. However, three of the nine patients electively 
restudied developed a restenosis,emphasizing the impor•
tance of close clinical follow-up in patients with multi vessel 
disease who undergo multi lesion coronary angioplasty. Each 
of the three asymptomatic patients had multi vessel disease 
at the time of restudy. 
Clinical implicati()ns. The present series supports the 
observations of M~bin et at. (32), who found an increased 
incidence of angina or need for bypass surgery in 35 patients 
with multi vessel disease and incomplete revascularization 
compared with 87 patients with single vessel and 31 patients 
with multi vessel disease who had complete revascularization 
(63 versus 29%; p < 0.001). Our data underscore the utility 
of multilesion coronary angioplasty as an important thera•
peutic option for selected patients with multivessel disease. 
The procedure can be performed in experienced medical 
centers with relatively low risk, perhaps only slightly greater 
than the risk for single vessel coronary disease. Anginal 
symptoms are significantly decreased in patients who achieve 
a primary success; 63% of our patients were asymptomatic 
6 months after the procedure. The improvement in anginal 
status occurs even in patients who have incomplete rev as•
cularization although the long-term clinical significance of 
residual myocardial ischemia in the incompletely revascU•
larized patient remains to be determined, particularly for 
patients with three vessel disease. 
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